On Oct 30, major Wall Street analysts update their ratings for $Tenet Healthcare (THC.US)$, with price targets ranging from $183 to $217.
BofA Securities analyst Joanna Gajuk initiates coverage with a buy rating, and sets the target price at $189.
UBS analyst A.J. Rice maintains with a buy rating, and adjusts the target price from $164 to $217.
Wells Fargo analyst Steve Baxter maintains with a buy rating, and maintains the target price at $195.
RBC Capital analyst Ben Hendrix maintains with a buy rating, and adjusts the target price from $136 to $183.
Truist Financial analyst David S Macdonald maintains with a buy rating, and adjusts the target price from $180 to $190.
Furthermore, according to the comprehensive report, the opinions of $Tenet Healthcare (THC.US)$'s main analysts recently are as follows:
Tenet Healthcare exhibited a robust performance across all segments for the third quarter, with notable strength in the hospital segment and the USPI segment meeting expectations. The company remains focused on prioritizing investments in the USPI segment as its foremost capital allocation, while also continuing to invest in significant hospital growth opportunities, especially after streamlining its hospital portfolio through a series of divestitures.
Tenet Healthcare demonstrated a noteworthy recovery from prior weaknesses in the hospital segment, buoyed by a robust third-quarter performance and an upward revision in guidance. The company's preliminary outlook for 2025 indicates the potential for sustained strong volume trends into the following year, along with ongoing expansion of capacity.
Here are the latest investment ratings and price targets for $Tenet Healthcare (THC.US)$ from 6 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
